{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "adds_modification",
    "modifications" : [ {
      "modification_type" : "glycosylation"
    } ],
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uniprot:P19883",
      "entity_text" : "follistatin",
      "entity_type" : "protein"
    },
    "is_direct" : false,
    "hypothesis_information" : false,
    "context" : {
      "Species" : [ "taxonomy:9606" ],
      "TissueType" : [ "tissuelist:TS-0079" ],
      "Cellular_component" : [ "go:GO:0005737" ],
      "Organ" : [ "uberon:UBERON:0000479" ]
    }
  },
  "verbose_text" : "Our decision to target liver cells is based on the fact that in humans the liver is a major contributor to circulating follistatin, implying that these cells are equipped to produce and secrete the fully mature and glycosylated follistatin protein XREF_BIBR.",
  "reading_complete" : "2020-08-03T16:49:28Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-03T16:47:37Z",
  "trigger" : "glycosylated",
  "evidence" : [ "glycosylated follistatin" ],
  "pmc_id" : "6276093",
  "score" : 0
}